Best Radioembolization for liver cancer Doctors Worldwide — TOP 27

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Prof. Merimsky specializes in liver cancer treatments at Sourasky Medical Center, with a focus on radioembolization and innovative oncology approaches.

• Over 41 years of experience of oncology experience, including academic and clinical roles
• Head of the Unit for Soft Tissue and Bone Oncology
• Member of ESMO Sarcoma group and IASLC ethical committee
• Trained at prestigious institutions like Institut Gustave Roussy in Paris
• Published extensive research in oncology and contributed to clinical studies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Solak specializes in gastrointestinal cancers, including liver cancer, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Trained at The University of Texas MD Anderson Cancer Center
• Specializes in breast, testicular, ovarian, lung, and head-neck cancers
• Works at Hisar Hospital Intercontinental

Specializes in interventional radiology with dual fellowships from Ege and Bursa Uludag Universities – focuses on liver cancer treatments at Memorial Bahçelievler Hospital.

• 21 years of experience in interventional radiology
• Member of Turkish Society of Interventional Radiology
• Trained at Tepecik Training and Research Hospital
• Performs advanced radioembolization procedures

Dr. Stepfansky directs the oncology hospitalization unit at Tel Aviv Medical Center–known for advanced liver cancer treatments like radioembolization.

• 26 years of experience specializing in oncology at Ichilov
• Leads clinical trials for new cancer therapies
• Board-certified in internal medicine and oncology
• Primary researcher in first-to-third phase oncology studies

Associate Professor Dr. Yusuf Acikgoz specializes in liver cancer treatments, including radioembolization, at Lokman Hekim University Ankara Hospital.

• Trained at Ohio State University in medical oncology
• Participated in Phase III clinical trials for advanced cancer treatments
• Certified in Good Clinical Practice and human subjects protection
• Member of the American Society of Clinical Oncology

Specializes in medical oncology with a focus on liver cancer treatments, including radioembolization, at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University, a leading institution in Turkey
• Worked at multiple prestigious hospitals, including Akdeniz University Hospital

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı, specializing in liver cancer treatments including radioembolization.

• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch at Prof. Dr. Cemil Taşcıoğlu City Hospital

Professor Kocakoc leads the Interventional Radiology Unit at Bahçelievler Medical Park Hospital, with extensive expertise in liver cancer treatments.

• Over 33 years of experience of experience in radiology
• Trained at University Hospital of Cleveland, Case Western Reserve University
• Multiple awards from European radiology societies
• Fellow of ESGAR and ESUR
• Published research on MR angiography and abdominal imaging

Professor Safadi leads the liver disease unit at Hadassah Medical Center, specializing in advanced liver treatments including radioembolization.

• Over 38 years of experience of experience in gastroenterology and hepatology
• Trained with Professor Scott Friedman at Sinai School of Medicine in New York
• Member of international liver study associations
• Author of numerous articles on liver disease treatment
• Recipient of multiple scientific awards for liver fibrosis research

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Shaunak specializes in liver cancer treatments, including radioembolization, with a strong focus on targeted therapies and molecular research.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Presented research on stomach cancer at ASCO Gastrointestinal Symposium
• Expertise in molecular basis of cancer and targeted therapies
• Senior Residency in Internal Medicine from Shyam Shah Medical College